Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Understanding these multifactorial causes is essential for developing effective, personalised weight management strategies during this challenging life stage
Readers can find HTA outcome tracking, reimbursement landscape analysis, and prescribing pattern insights
However, concerns are emerging related to the potential loss of muscle mass linked to these treatments , with significant implications for long-term health, as came out of a recent editorial in the prestigious journal The Lancet entitled Muscle matters: the effects of medically induced weight loss on skeletal muscle, which underlined how GLP-1 receptor agonists have revolutionised the treatment of obesity and proven to be effective in reducing body weight
This video analyzes Eli Lilly's Q1 2026 earnings call, discussing key products like eloralintide, brenipatide, and retatrutide, providing essential finance news and stock market news for those tracking pharmaceutical companies
